| 摘要 |
PROBLEM TO BE SOLVED: To obtain a new abnormal tactile sensation-treating agent capable of accelerating functional recovery from a decline or loss of the tactile function of skin. SOLUTION: This new abnormal tactile sensation-treating agent includes Neurotropin such as BDNF(brain-derived neurotrophic factor) as an active ingredient. The agent is helpful for the therapy of skin imperception (especially loss or deterioration of tactile sensation) caused by various peripheral and/or central nervous disorders due to vitamin deficiency, intoxication, inflammatory disease, virus infection, diabetic, therapy using an anticancer drug, external wound, physical stimulation in occupational environment or the like, psychosomatic disorder, or the like.
|
